Physiological and pathological roles of Apaf1 and the apoptosome

Different cellular pathways can lead to apoptosis. Apaf1 is the molecular core of the apoptosome, a multiproteic complex mediating the so‐called mitochondrial pathway of cell death. The importance of this pathway during development has been clearly demonstrated by knocking out key genes. Also, the relevance of Apaf1 dosage during development has been recently underlined. Moreover, a growing body of evidences seems to point out a possible role of the mitochondria‐dependent apoptosis in different pathologies. In particular, we discuss here some recent evidences regarding the putative role of the apoptosome in neurodegeneration and cancer.

[1]  R. Gilbertson Paediatric embryonic brain tumours. biological and clinical relevance of molecular genetic abnormalities. , 2002, European journal of cancer.

[2]  R. Tanzi,et al.  Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. , 1997, Science.

[3]  K. Lindenberg,et al.  Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. , 2002, Molecular cell.

[4]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[5]  David S. Park,et al.  APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death , 2001, The Journal of cell biology.

[6]  J. Octave,et al.  Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. , 2002, The Journal of biological chemistry.

[7]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[8]  S. Srinivasula,et al.  Negative regulation of cytochrome c‐mediated oligomerization of Apaf‐1 and activation of procaspase‐9 by heat shock protein 90 , 2000, The EMBO journal.

[9]  J. Marx New Leads on the 'How' of Alzheimer's , 2001, Science.

[10]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[11]  P. Nicotera Apoptosis and age-related disorders: role of caspase-dependent and caspase-independent pathways. , 2002, Toxicology letters.

[12]  C. Bergeron,et al.  Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.

[13]  C. Cotman,et al.  Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. , 2001, The American journal of pathology.

[14]  A. Yakovlev,et al.  Differential Expression of Apoptotic Protease-Activating Factor-1 and Caspase-3 Genes and Susceptibility to Apoptosis during Brain Development and after Traumatic Brain Injury , 2001, The Journal of Neuroscience.

[15]  J. Liu,et al.  Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. , 2002, Cancer research.

[16]  S. Rabacchi,et al.  Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid , 2000, The Journal of Neuroscience.

[17]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[18]  Carl W. Cotman,et al.  β-Amyloid Induces Local Neurite Degeneration in Cultured Hippocampal Neurons: Evidence for Neuritic Apoptosis , 1998, Neurobiology of Disease.

[19]  Dale E. Bredesen,et al.  Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract* , 1998, The Journal of Biological Chemistry.

[20]  R. Moritz,et al.  HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins* , 2002, The Journal of Biological Chemistry.

[21]  T. Furukawa,et al.  Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. , 1998, Cancer research.

[22]  S. B. Bratton,et al.  Recruitment, activation and retention of caspases‐9 and ‐3 by Apaf‐1 apoptosome and associated XIAP complexes , 2001, The EMBO journal.

[23]  K. Yoshikawa,et al.  Activation of Neuronal Caspase-3 by Intracellular Accumulation of Wild-Type Alzheimer Amyloid Precursor Protein , 1999, Journal of Neuroscience.

[24]  K. Vousden,et al.  Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .

[25]  P. Jones,et al.  Cancer: Death and methylation , 2001, Nature.

[26]  T. Mak,et al.  Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis. , 2001, Cancer research.

[27]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[28]  D. Cleveland,et al.  Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Beal,et al.  Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.

[30]  D. Bredesen,et al.  An alternative, nonapoptotic form of programmed cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Tagle,et al.  Mutant Huntingtin Expression in Clonal Striatal Cells: Dissociation of Inclusion Formation and Neuronal Survival by Caspase Inhibition , 1999, The Journal of Neuroscience.

[32]  A. Faden,et al.  Multiple caspases are involved in β‐amyloid‐induced neuronal apoptosis , 2001 .

[33]  M. Fukushima,et al.  Cisplatin‐induced in vivo differentiation of human embryonal carcinoma , 2002, BJU international.

[34]  A. Asai,et al.  Over‐expression of APAF‐1 and caspase‐9 augments radiation‐induced apoptosis in U‐373MG glioma cells , 2001, International journal of cancer.

[35]  Betty Y. S. Kim,et al.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.

[36]  S. Lowe,et al.  Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. , 1999, Science.

[37]  G. Mills,et al.  Defective Cytochrome c-dependent Caspase Activation in Ovarian Cancer Cell Lines due to Diminished or Absent Apoptotic Protease Activating Factor-1 Activity* , 2001, The Journal of Biological Chemistry.

[38]  M. Tabaton,et al.  Alternative, Non-secretase Processing of Alzheimer’s β-Amyloid Precursor Protein during Apoptosis by Caspase-6 and -8* , 1999, The Journal of Biological Chemistry.

[39]  F. Cecconi,et al.  Apaf1 and the apoptotic machinery , 1999, Cell Death and Differentiation.

[40]  K. Helin,et al.  Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.

[41]  G. Kroemer,et al.  The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.

[42]  J. Blenis,et al.  Caspase-8 Is Required for Cell Death Induced by Expanded Polyglutamine Repeats , 1999, Neuron.

[43]  Emad S. Alnemri,et al.  Negative regulation of the Apaf-1 apoptosome by Hsp70 , 2000, Nature Cell Biology.

[44]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[45]  Xiaodong Wang,et al.  Apaf-1 deficiency and neural tube closure defects are found in fog mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Cotman,et al.  Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8 , 1999, Neurobiology of Disease.

[47]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[48]  S. Rabacchi,et al.  Caspase-2 mediates neuronal cell death induced by beta-amyloid. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[49]  M. MacFarlane,et al.  Initiation of Apaf-1 translation by internal ribosome entry , 2000, Oncogene.

[50]  R. Kucherlapati,et al.  Genetic analysis of the APAF1 gene in male germ cell tumors , 2000, Genes, chromosomes & cancer.

[51]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[52]  M. Vila,et al.  Instrumental Activation of Bid by Caspase-1 in a Transgenic Mouse Model of ALS , 2002, Molecular and Cellular Neuroscience.

[53]  C. Marshall Tumor suppressor genes , 1991, Cell.

[54]  Xuejun Jiang,et al.  Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. , 2002, Molecular cell.

[55]  Guido Kroemer,et al.  Hsp27 negatively regulates cell death by interacting with cytochrome c , 2000, Nature Cell Biology.

[56]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[57]  T. Sunderland,et al.  Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.

[58]  F. Cecconi,et al.  Apaf1 reduced expression levels generate a mutant phenotype in adult brain and skeleton , 2002, Cell Death and Differentiation.

[59]  M. Valentine,et al.  Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN , 2002, Oncogene.

[60]  S. Love,et al.  Neuronal death in brain infarcts in man , 2000, Neuropathology and Applied Neurobiology.

[61]  D. Givol,et al.  A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1 , 2002, Oncogene.

[62]  R. Jackson,et al.  Protein Factor Requirements of the Apaf-1 Internal Ribosome Entry Segment: Roles of Polypyrimidine Tract Binding Protein and upstream of N-ras , 2001, Molecular and Cellular Biology.

[63]  O. Hansson,et al.  Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  C. Cotman,et al.  Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. , 1999, Neurobiology of disease.

[65]  M. Perucho,et al.  Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype , 2000, Cell Death and Differentiation.

[66]  A. Faden,et al.  Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. , 2001, Journal of neuroscience research.

[67]  A. LeBlanc,et al.  Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neurons , 2002, The Journal of cell biology.

[68]  S. Chandra,et al.  A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor , 2000, Nature Medicine.

[69]  K. Jellinger,et al.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. , 1999, The American journal of pathology.

[70]  G. Salvesen,et al.  Caspases on the brain , 2002, Journal of neuroscience research.

[71]  Y. Okamura-Oho,et al.  Expression of extended polyglutamine sequentially activates initiator and effector caspases. , 1999, Biochemical and biophysical research communications.

[72]  K Paliga,et al.  Proteolytic Processing of the Alzheimer’s Disease Amyloid Precursor Protein within Its Cytoplasmic Domain by Caspase-like Proteases* , 1999, The Journal of Biological Chemistry.

[73]  K. Tamayose,et al.  An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Francesco Cecconi,et al.  Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development , 1998, Cell.

[75]  P. Nicotera,et al.  Apoptosis in Caspase-inhibited Neurons , 2001, Molecular medicine.

[76]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[77]  Gideon Rechavi,et al.  DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1 , 2001, Oncogene.

[78]  John Calvin Reed,et al.  Apaf-1/Cytochrome c-independent and Smac-dependent Induction of Apoptosis in Multiple Myeloma (MM) Cells* , 2001, The Journal of Biological Chemistry.

[79]  S. Chandra,et al.  A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. , 2000, Nature medicine.

[80]  Jean-Claude Martinou,et al.  Breaking the mitochondrial barrier , 2001, Nature Reviews Molecular Cell Biology.

[81]  Y. Suh,et al.  Amyloid &bgr; peptide induces cytochrome c release from isolated mitochondria , 2002, Neuroreport.

[82]  M. Greenberg,et al.  β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand , 2001, The Journal of Neuroscience.

[83]  G. Forloni,et al.  Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. , 1996, Molecular and chemical neuropathology.

[84]  Stephen B. Dunnett,et al.  Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation , 1999, The Journal of Neuroscience.

[85]  A. Hackam,et al.  Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi , 2002, Nature Cell Biology.

[86]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[87]  G. Robertson,et al.  Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. , 1999, Cell.

[88]  A. Hackam,et al.  Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal Cells* , 2000, The Journal of Biological Chemistry.

[89]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[90]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[91]  S. Lipton,et al.  Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.

[92]  R. Burke,et al.  Activation of Caspase‐3 in Developmental Models of Programmed Cell Death in Neurons of the Substantia Nigra , 1999, Journal of neurochemistry.

[93]  P. Stieg,et al.  Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. , 2000, Science.

[94]  Xiantao Wang,et al.  Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis. , 2002, Brain : a journal of neurology.